Some recent published studies have demonstrated that CCL20 promoted cancer progression by some pathways such as by activating p38 pathway in laryngeal cancer [80], through PI3K pathway in LC and via NF-kappa B pathway in thyroid cancer [81, 82]. The gene discussed is CCL20; the disease is laryngotracheoesophageal cleft.